Lee Ainslie - Maverick Capital
Holding/activity history for Supernus Pharmaceuticals, Inc. (SUPN)
← All SUPN superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $27.26–32.98 · VW $30.25i | SEC | |
| 2023 Q2 | 7,409 | <0.01 | Reduce 11.86% | <0.01 | $29.59–39.09 · VW $33.92i | $222,715 | SEC |
| 2023 Q1 | 8,406 | 0.01 | Add 9.01% | <0.01 | $34.33–42.09 · VW $38.34i | $304,549 | SEC |
| 2022 Q4 | 7,711 | <0.01 | Reduce 13.22% | <0.01 | $30.00–38.40 · VW $34.87i | $275,051 | SEC |
| 2022 Q3 | 8,886 | 0.01 | Buy | 0.01 | $28.16–36.08 · VW $32.92i | $301,000 | SEC |
| 2022 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $27.87–33.30 · VW $30.93i | SEC | |
| 2021 Q4 | 4,000 | <0.01 | Reduce 90.47% | 0.01 | $26.13–34.50 · VW $30.13i | $117,000 | SEC |
| 2021 Q3 | 41,962 | 0.01 | Reduce 26.71% | <0.01 | $23.15–31.73 · VW $27.12i | $1,119,000 | SEC |
| 2021 Q2 | 57,251 | 0.02 | Buy | 0.02 | $25.84–34.29 · VW $30.27i | $1,763,000 | SEC |
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $23.18–31.99 · VW $27.45i | SEC | |
| 2020 Q4 | 1,711 | <0.01 | Reduce 97.41% | 0.03 | $17.20–27.55 · VW $22.22i | $43,000 | SEC |
| 2020 Q3 | 66,177 | 0.03 | Buy | 0.03 | $19.97–25.82 · VW $22.55i | $1,379,000 | SEC |
Price snapshot:
Current price$47.35
52-week low$32.20
52-week high$59.68